Quotient Sciences and CPI Form Joint Venture to Accelerate RNA Drug Development

Quotient Sciences, a leading global drug development and manufacturing accelerator, and UK technology innovation centre, CPI, have signed a memorandum of...

September 03, 2025 | Wednesday | News
CDT Equity Unveils New Target and Indication for AZD1656 via AI-Driven Drug Repurposing Strategy

CDT Equity Inc.  announces that it has successfully identified a new biological target and novel therapeutic indication for its lead programme, AZD1...

August 27, 2025 | Wednesday | News
Sygnature Discovery Doubles High-Throughput Chemistry Capacity with £1M Investment

  Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), today announces the completion of a major enhancemen...

July 24, 2025 | Thursday | News
iFIT and Samsung Health Partner to Redefine Connected Fitness and Personalised Healthcare Globally

iFIT, a global leader in connected fitness and interactive content,  announced a groundbreaking partnership with Samsung Health, one of the world&rs...

July 14, 2025 | Monday | News
Purespring Therapeutics Receives FDA Clearance to Initiate Clinical Trials for IgA Nephropathy Gene Therapy

Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, announces that the U.S. Food and Drug A...

July 10, 2025 | Thursday | News
Conduit Pharmaceuticals Expands IP Portfolio with Four New Patent Filings for AZD1656 and AZD5658

Conduit Pharmaceuticals Inc.  announces the filing of four new patent applications relating to its key assets AZD1656 and AZD5658, including the Com...

July 08, 2025 | Tuesday | News
Oxford BioTherapeutics Achieves Milestone as Boehringer Ingelheim Selects Third Cancer Drug Candidate for IND-Enabling Studies

Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford BioTherapeutics’ proprietary OGA...

July 07, 2025 | Monday | News
Symbiotic.blue Launches in the UK to Redesign Drug Discovery with Brain-Inspired AI

Symbiotic.blue, the UK’s newest Techbio company has launched to innovate a next-generation artificial intelligence-driven drug discovery (AIDD) pla...

June 20, 2025 | Friday | News
Draig Therapeutics Launches with $140M to Advance Novel Neuropsychiatric Treatments

Clinical-stage company led by world-class team targeting core neurotransmission pathways underlying neuropsychiatric disorders with a rich pipeline of ...

June 19, 2025 | Thursday | News
University of Oxford and ReciBioPharm Expand Collaboration to Manufacture Malaria Vaccine Candidates

  Expands the collaboration to manufacture two malaria vaccine candidates (R78C and RH5.1) for Phase 1/2 clinical trials. Delivers the sixth m...

June 17, 2025 | Tuesday | News
SynaptixBio Advances First Clinical Candidate for Rare H-ABC Disease With Promising Antisense Oligonucleotide Therapy

SynaptixBio, the only company licensed to commercialise a treatment for a rare, deadly disease, says the drug could halt disease progression and even rever...

June 11, 2025 | Wednesday | News
Conduit Pharmaceuticals and Manoira Partner to Advance Cross-Species Glucokinase Activator Programs in $15B Animal Health Market

Collaboration leverages cutting-edge reformulation expertise to generate cross-species insights, fast-track human clinical programs, and seeks to captu...

June 05, 2025 | Thursday | News
Nxera Pharma Reaches Key Development Milestone in Diabetes Collaboration with Eli Lilly

Nxera Pharma Co., Ltd. announces that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly a...

June 02, 2025 | Monday | News
Alvotech and Advanz Pharma Expand Biosimilars Partnership with Three New Candidates in Europe

Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a U...

May 29, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close